🔴 Senti Biosciences is trading 12.45% down today as immediate cause remains uncertain

Senti Biosciences is trading at $0.34, down 12.45%, as the immediate cause of the August 24 decline remains uncertain.

• Closed at $0.39 on August 21, 2026; no new company-specific catalyst was identified.
• The latest available quarterly report showed a $12.75 million net loss, $17,000 in revenue, and an EPS miss versus estimates; liquidity concerns remain.
• The Nasdaq fell 0.60%, but broader market weakness does not clearly explain the outsized move.